- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01852656
Effectiveness of Influenza Vaccine Reminder Systems
The Effectiveness and Cost of Different Methods of Reminders for Annual Influenza Immunization Among Adults With Asthma and Chronic Obstructive Pulmonary Disease
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 80237
- Kaiser Permanente Colorado
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 19 to 64 years
- Enrolled in Kaiser Permanente Colorado health plan
- Diagnosis of asthma and/or chronic obstructive pulmonary disease
Exclusion Criteria:
- Subjects living in households with other individuals in high-risk categories for influenza morbidity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Postcard Only Reminder Group
In the postcard reminder intervention, the member will receive a single postcard, addressed to the member with asthma or COPD.
|
Postcard: The postcard will be sent as a single postcard to each individual on the list.
The postcard will be sent to the home address of the member.
If the postcard is returned, due to an inaccurate address, the postcard will not be re-sent.
The postcard does not identify that the member has a chronic health condition such as asthma or COPD.
The postcard will be mailed during the last two weeks of September, 2012.
|
|
Active Comparator: IVR Only Reminder Group
In the IVR reminder intervention, targeted members will be contacted by the interactive voice response system
|
IVR: Subjects in this reminder group will receive an automated telephone call to their primary telephone number.
A total of 2 call attempts per member will be made.
The IVR system will provide a message about the importance of annual influenza vaccination.
The member can also request additional information about influenza vaccination and influenza vaccination locations and times.
|
|
Active Comparator: Postcard and IVR Reminder Group
In this group, individuals will receive both a postcard reminder and an IVR reminder.
|
IVR: Subjects in this reminder group will receive an automated telephone call to their primary telephone number. A total of 2 call attempts per member will be made. The IVR system will provide a message about the importance of annual influenza vaccination. The member can also request additional information about influenza vaccination and influenza vaccination locations and times. Postcard: The postcard will be sent as a single postcard to each individual on the list. The postcard will be sent to the home address of the member. If the postcard is returned, the postcard will not be re-sent. The postcard does not identify that the member has a chronic health condition such as asthma or COPD. The postcard will be mailed during the last two weeks of September, 2012. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Receipt of influenza vaccine
Time Frame: up to 7 months
|
The 2012-2013 influenza season, defined as October to April.
|
up to 7 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total unit cost per outreach method
Time Frame: up to 10 months
|
The time in months to develop, plan, and implement the intervention arms, as a function of cost.
|
up to 10 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Matthew F. Daley, MD, Kaiser Permanente
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Immune System Diseases
- Hypersensitivity, Immediate
- Bronchial Diseases
- Respiratory Hypersensitivity
- Hypersensitivity
- Orthomyxoviridae Infections
- Lung Diseases
- Lung Diseases, Obstructive
- Pulmonary Disease, Chronic Obstructive
- Asthma
- Influenza, Human
Other Study ID Numbers
- 12010936
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.